Coagulation assays

被引：175

作者：

Bates, SM

Weitz, JI

机构：

[1] McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada

[2] McMaster Univ, Dept Med, Hamilton, ON L8V 1C3, Canada

[3] McMaster Univ, Dept Biochem & Med Sci, Hamilton, ON L8V 1C3, Canada

来源：

CIRCULATION | 2005年 / 112卷 / 04期

关键词：

D O I：

10.1161/CIRCULATIONAHA.104.478222

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E53 / E60

页数：8

共 55 条

[1]

ALHENCGELAS M, 1994, THROMB HAEMOSTASIS, V71, P698

[2]

[Anonymous], 1994, Hemostasis and thrombosis: basic principle and clinical practice

[3] The pharmacology and management of the vitamin K antagonists [J].

Ansell, J ;

Hirsh, J ;

Poller, L ;

Bussey, H ;

Jacobson, A ;

Hylek, E .

CHEST, 2004, 126 (03) :204S-233S

[4] Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin [J].

Bates, SM ;

Weitz, JI ;

Johnston, M ;

Hirsh, J ;

Ginsberg, JS .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :385-391

[5] Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No [J].

Bounameaux, H ;

De Moerloose, P .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) :551-554

[6] Relationship between activated clotting time and ischemic or hemorrhagic complications - Analysis of 4 recent randomized clinical trials of percutaneous coronary intervention [J].

Brener, SJ ;

Moliterno, DJ ;

Lincoff, AM ;

Steinhubl, SR ;

Wolski, KE ;

Topol, EJ .

CIRCULATION, 2004, 110 (08) :994-998

[7] ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY [J].

BRILLEDWARDS, P ;

GINSBERG, JS ;

JOHNSTON, M ;

HIRSH, J .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :104-109

[8] RELIANCE ON PROTHROMBIN TIME RATIOS CAUSES SIGNIFICANT ERRORS IN ANTICOAGULATION THERAPY [J].

BUSSEY, HI ;

FORCE, RW ;

BIANCO, TM ;

LEONARD, AD .

ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) :278-282

[9] Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration [J].

Casserly, IP ;

Kereiakes, DJ ;

Gray, WA ;

Gibson, PH ;

Lauer, MA ;

Reginelli, JP ;

Moliterno, DJ .

THROMBOSIS RESEARCH, 2004, 113 (02) :115-121

[10] THE STRUCTURE OF HEPARIN OLIGOSACCHARIDE FRAGMENTS WITH HIGH ANTI-(FACTOR-XA) ACTIVITY CONTAINING THE MINIMAL ANTITHROMBIN-III-BINDING SEQUENCE - CHEMICAL AND C-13 NMR-STUDIES [J].

CASU, B ;

ORESTE, P ;

TORRI, G ;

ZOPPETTI, G ;

CHOAY, J ;

LORMEAU, JC ;

PETITOU, M ;

SINAY, P .

BIOCHEMICAL JOURNAL, 1981, 197 (03) :599-609

← 1 2 3 4 5 6 →